Daily oral emtricitabine/tenofovir preexposure prophylaxis and herpes simplex virus type 2 among men who have sex with men.

导出 OA

翻译打印收藏纠错

第一作者： Julia L,Marcus

第一单位： Gladstone Institute of Virology and Immunology, San Francisco, California, United States or America; University of California, Berkeley, California, United States of America.

作者： Julia L,Marcus ^[1] ; David V,Glidden ^[2] ; Vanessa,McMahan ^[3] ; Javier R,Lama ^[4] ; Kenneth H,Mayer ^[5] ; Albert Y,Liu ^[6] ; Orlando,Montoya-Herrera ^[7] ; Martin,Casapia ^[8] ; Brenda,Hoagland ^[9] ; Robert M,Grant ^[10]

作者单位： Gladstone Institute of Virology and Immunology, San Francisco, California, United States or America; University of California, Berkeley, California, United States of America. ^[1] University of California San Francisco, San Francisco, California, United States of America. ^[2] Gladstone Institute of Virology and Immunology, San Francisco, California, United States or America. ^[3] Asociación Civil Impacta Salud y Educación, Lima, Peru. ^[4] Fenway Institute, Fenway Health, Boston, Massachusetts, United States of America; Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America. ^[5] Bridge HIV, San Francisco Department of Public Health, San Francisco, California, United States of America. ^[6] Fundación Ecuatoriana Equidad, Guayaquil, Guayas, Ecuador. ^[7] Asociación Civil Selva Amazónica, Iquitos, Peru. ^[8] Instituto de Pesquisa Clínica Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil. ^[9] Gladstone Institute of Virology and Immunology, San Francisco, California, United States or America; University of California San Francisco, San Francisco, California, United States of America. ^[10]